Towards tuberculosis elimination: an action framework for low-incidence countries

…, J Bruchfeld, F Castelli, R Centis… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

…, JCM Brust, Y Cai, E Caumes, JP Cegielski, R Centis… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …

[HTML][HTML] Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects

D Visca, CWM Ong, S Tiberi, R Centis, L D'ambrosio… - Pulmonology, 2021 - Elsevier
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between these …

[HTML][HTML] Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

…, MC Becerra, A Benedetti, M Burgos, R Centis… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

…, J Cardoso-Landivar, R Centis… - European …, 2020 - Eur Respiratory Soc
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

G Sotgiu, R Centis, L D'Ambrosio… - European …, 2012 - Eur Respiratory Soc
Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study

…, RR Leyet, L D'Ambrosio, R Centis… - European …, 2017 - Eur Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

…, S Keshavjee, K DeRiemer, R Centis… - European …, 2013 - Eur Respiratory Soc
… help in the following ways: data gathering in the Philippines by R. Guilatco, G. Balane, and
M. … Lin; secretarial and administrative assistance by R. Choe and S. Ramoutar; statistical and …

[HTML][HTML] Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

…, ZF Udwadia, M Vitacca, R Centis… - … of Tuberculosis and …, 2021 - ingentaconnect.com
BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes
significant morbidity and mortality. The aim of these clinical standards is to provide guidance …

[HTML][HTML] Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020

…, M Calnan, PF Castellotti, R Centis… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in 16
countries on 5 continents showed that attendance at tuberculosis centers was lower during …